— Know what they know.
Not Investment Advice

IART NASDAQ

Integra LifeSciences Holdings Corporation
1W: +4.3% 1M: +40.6% 3M: +23.8% YTD: +25.9% 1Y: +13.5% 3Y: -69.1% 5Y: -78.6%
$15.10
-0.02 (-0.13%)
 
Weekly Expected Move ±14.7%
$10 $12 $14 $16 $18
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Strong Buy · Power 68 · $1.2B mcap · 59M float · 1.65% daily turnover · Short 60% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
39.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 3.5%  ·  5Y Avg: 2.9%
Cost Advantage ★
58
Intangibles
30
Switching Cost
39
Network Effect
33
Scale
40
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IART has No discernible competitive edge (39.8/100). The business operates without significant structural advantages. The primary source of advantage is Cost Advantage. ROIC of 3.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$12
Avg Target
$14
High
Based on 2 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 11Hold: 10Sell: 5Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$12.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-04-15 Truist Financial Richard Newitter $15 $12 -3 +9.0% $11.01
2025-10-15 Truist Financial $26 $15 -11 +1.7% $14.76
2024-10-07 BTIG Ryan Zimmerman $22 $20 -2 +14.7% $17.43
2024-07-30 Truist Financial Richard Newitter $32 $26 -6 +5.7% $24.59
2024-07-29 Citigroup Joanne Wuensch Initiated $23 -9.5% $25.42
2024-07-29 BTIG Ryan Zimmerman Initiated $22 -13.5% $25.42
2024-07-16 Truist Financial Richard Newitter $25 $32 +7 +7.2% $29.84
2024-05-07 Truist Financial Richard Newitter Initiated $25 +8.0% $23.14
2024-05-07 JMP Securities David Turkaly Initiated $40 +72.9% $23.14
2024-05-06 Wells Fargo Vik Chopra $74 $25 -49 +8.0% $23.14
2022-10-26 Piper Sandler Matt O'Brien $55 $50 -5 +6.7% $46.85
2022-07-28 Piper Sandler FY22 EPS Initiated $55 -2.7% $56.53
2021-04-28 RBC Capital Shagun Singh Chadha Initiated $74 -1.4% $75.07
2021-04-28 Wells Fargo Larry Biegelsen Initiated $74 -1.4% $75.07

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

C+
May 22, 2026
DCF
4
ROE
1
ROA
1
D/E
1
P/E
1
P/B
4
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IART receives an overall rating of C+. Strongest factors: DCF (4/5), P/B (4/5). Areas of concern: ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-05-08 B- C+
2026-05-05 C- B-
2026-05-05 C+ C-
2026-02-27 C C+
2026-02-26 C+ C
2026-01-03 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

17 Grade D
Profitability
23
Balance Sheet
31
Earnings Quality
36
Growth
33
Value
49
Momentum
36
Safety
15
Cash Flow
22
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IART scores highest in Value (49/100) and lowest in Safety (15/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.64
Distress Zone
Piotroski F-Score
5/9
Beneish M-Score
-3.34
Unlikely Manipulator
Ohlson O-Score
-5.22
Bankruptcy prob: 0.5%
Low Risk
Credit Rating
B+
Score: 30.6/100
Trend: Improving
Earnings Quality
OCF/NI: -0.14x
Accruals: -14.9%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IART scores 0.64, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IART scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IART's score of -3.34 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IART's implied 0.5% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IART receives an estimated rating of B+ (score: 30.6/100), with a improving trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-2.34x
PEG
0.00x
P/S
0.71x
P/B
1.11x
P/FCF
-71.61x
P/OCF
10.15x
EV/EBITDA
-9.11x
EV/Revenue
1.52x
EV/EBIT
-5.86x
EV/FCF
-246.43x
Earnings Yield
-68.40%
FCF Yield
-1.40%
Shareholder Yield
0.03%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IART currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.925
NI / EBT
×
Interest Burden
1.258
EBT / EBIT
×
EBIT Margin
-0.259
EBIT / Rev
×
Asset Turnover
0.431
Rev / Assets
×
Equity Multiplier
2.951
Assets / Equity
=
ROE
-38.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IART's ROE of -38.3% is driven by Asset Turnover (0.431), indicating efficient use of assets to generate revenue. A tax burden ratio of 0.93 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$15.10
Median 1Y
$11.42
5th Pctile
$5.42
95th Pctile
$24.06
Ann. Volatility
44.2%
Analyst Target
$12.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Mojdeh Poul
President and Chief Executive Officer and Director
$1,009,616 $5,219,868 $9,375,551
Lea Knight Financial
Vice President and Chief Financial Officer
$638,646 $1,498,719 $2,882,994
Michael J. McBreen
Executive Vice President, President, Codman Specialty Surgical
$643,750 $1,327,764 $2,713,278
Robert T. Davis,
Jr Executive Vice President, President, Tissue Technologies
$583,354 $892,712 $1,912,633
Harvinder Singh President,
Vice President, President, International
$563,993 $683,126 $1,625,444
Jan De Witte
Former President and Chief Executive Officer and Director
$42,308 $— $282,679

CEO Pay Ratio

59:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $9,375,551
Avg Employee Cost (SGA/emp): $158,053
Employees: 4,427

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
4,427
+0.7% YoY
Revenue / Employee
$369,380
Rev: $1,635,245,000
Profit / Employee
$-116,665
NI: $-516,474,000
SGA / Employee
$158,053
Avg labor cost proxy
R&D / Employee
$22,356
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 14.0% 14.8% 10.6% 9.8% 10.4% 10.8% 10.3% 9.9% 7.5% 5.8% 4.0% 2.4% 1.4% -0.4% -0.4% -1.8% -32.0% -31.6% -39.9% -38.3% -38.30%
ROA 5.9% 6.3% 4.6% 4.2% 4.5% 4.7% 4.7% 4.5% 3.4% 2.6% 1.8% 1.0% 0.6% -0.2% -0.2% -0.7% -12.8% -12.7% -13.5% -13.0% -12.98%
ROIC 7.6% 7.6% 5.5% 6.3% 6.7% 6.9% 6.8% 6.5% 5.1% 4.2% 3.1% 2.3% 1.9% 0.8% 0.7% 0.2% -12.1% -11.0% 1.9% 3.5% 3.48%
ROCE 7.6% 7.5% 7.0% 6.2% 6.6% 7.0% 7.2% 7.1% 5.7% 4.6% 3.8% 2.8% 2.5% 1.5% 1.7% 1.1% -15.4% -14.9% -15.2% -13.5% -13.54%
Gross Margin 61.2% 62.7% 61.5% 62.1% 62.7% 61.5% 62.8% 61.1% 54.3% 57.1% 57.0% 56.1% 54.0% 52.6% 56.3% 50.8% 50.4% 56.2% 49.5% 57.2% 57.22%
Operating Margin 13.3% 14.6% 14.4% 12.3% 15.0% 16.9% 17.0% 9.6% 3.3% 7.0% 9.1% 1.1% -0.7% -2.1% 8.0% -4.0% -1.2% 10.0% 1.3% 10.2% 10.23%
Net Margin 9.0% 11.2% 11.2% 8.7% 11.3% 13.0% 13.3% 6.4% 1.1% 5.1% 5.0% -0.9% -3.0% -2.8% 4.4% -6.6% -1.2% -1.3% -0.4% -1.2% -1.18%
EBITDA Margin 21.3% 22.8% 22.2% 20.0% 23.8% 26.7% 26.2% 19.5% 12.4% 16.3% 18.5% 10.6% 9.6% 9.2% 17.9% 6.8% -1.1% 13.4% 15.2% 20.0% 20.03%
FCF Margin 18.7% 19.3% 17.1% 14.9% 13.1% 12.0% 14.0% 12.8% 10.0% 7.1% 4.7% 4.0% 3.8% 2.4% 0.9% -1.6% -2.9% -0.9% -2.8% -0.6% -0.62%
OCF Margin 20.6% 21.2% 20.3% 18.5% 16.8% 15.9% 17.0% 15.8% 13.5% 10.8% 9.1% 8.5% 9.0% 8.8% 8.0% 6.3% 4.4% 5.4% 3.1% 4.3% 4.34%
ROE 3Y Avg snapshot only -15.62%
ROE 5Y Avg snapshot only -5.61%
ROA 3Y Avg snapshot only -4.47%
ROIC 3Y Avg snapshot only 1.28%
ROIC Economic snapshot only 3.22%
Cash ROA snapshot only 1.98%
Cash ROIC snapshot only 2.54%
CROIC snapshot only -0.36%
NOPAT Margin snapshot only 5.95%
Pretax Margin snapshot only -32.59%
R&D / Revenue snapshot only 5.94%
SGA / Revenue snapshot only 42.35%
SBC / Revenue snapshot only 1.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 28.33 27.04 33.99 34.59 27.17 20.42 25.98 27.50 25.43 30.22 50.36 68.49 95.39 -212.26 -251.56 -58.07 -1.87 -2.22 -1.85 -1.46 -2.344
P/S Ratio 3.86 3.84 3.73 3.47 2.88 2.26 3.01 3.03 2.16 1.98 2.21 1.80 1.44 0.89 1.08 1.04 0.58 0.67 0.58 0.44 0.714
P/B Ratio 3.84 3.86 3.41 3.21 2.68 2.10 2.60 2.62 1.85 1.69 2.15 1.74 1.42 0.87 1.13 1.09 0.61 0.71 0.91 0.69 1.115
P/FCF 20.67 19.88 21.73 23.32 22.07 18.76 21.58 23.68 21.50 27.77 46.67 45.23 38.30 36.52 116.35 -66.05 -19.80 -76.03 -21.06 -71.61 -71.614
P/OCF 18.77 18.09 18.39 18.82 17.19 14.22 17.74 19.19 16.04 18.30 24.37 21.27 15.92 10.11 13.50 16.43 13.24 12.32 18.92 10.15 10.146
EV/EBITDA 19.26 19.61 18.84 19.52 16.28 12.91 15.55 15.69 13.74 14.67 18.60 18.60 16.87 14.71 17.89 18.82 -7.98 -8.98 -8.35 -9.11 -9.115
EV/Revenue 4.64 4.61 4.47 4.21 3.62 2.99 3.76 3.78 2.92 2.74 3.10 2.70 2.32 1.76 2.15 2.09 1.63 1.71 1.67 1.52 1.517
EV/EBIT 28.58 29.26 28.43 30.70 25.14 19.55 22.92 23.42 22.07 25.67 36.12 41.72 42.12 51.64 65.99 103.49 -5.51 -6.06 -5.71 -5.86 -5.856
EV/FCF 24.87 23.90 26.09 28.28 27.70 24.88 26.97 29.56 29.06 38.46 65.45 67.76 61.61 72.60 230.34 -133.26 -55.92 -194.30 -60.17 -246.43 -246.426
Earnings Yield 3.5% 3.7% 2.9% 2.9% 3.7% 4.9% 3.8% 3.6% 3.9% 3.3% 2.0% 1.5% 1.0% -0.5% -0.4% -1.7% -53.4% -45.0% -54.2% -68.4% -68.40%
FCF Yield 4.8% 5.0% 4.6% 4.3% 4.5% 5.3% 4.6% 4.2% 4.7% 3.6% 2.1% 2.2% 2.6% 2.7% 0.9% -1.5% -5.0% -1.3% -4.7% -1.4% -1.40%
PEG Ratio snapshot only 0.001
EV/OCF snapshot only 34.913
EV/Gross Profit snapshot only 2.851
Acquirers Multiple snapshot only 20.132
Shareholder Yield snapshot only 0.03%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 3.09 3.09 3.39 3.39 3.39 3.39 3.62 3.62 3.62 3.62 3.45 3.45 3.45 3.45 1.17 1.17 1.17 1.17 2.54 2.54 2.543
Quick Ratio 2.31 2.31 2.46 2.46 2.46 2.46 2.61 2.61 2.61 2.61 2.18 2.18 2.18 2.18 0.71 0.71 0.71 0.71 1.46 1.46 1.462
Debt/Equity 1.09 1.09 0.99 0.99 0.99 0.99 0.90 0.90 0.90 0.90 1.06 1.06 1.06 1.06 1.28 1.28 1.28 1.28 1.95 1.95 1.948
Net Debt/Equity 0.78 0.78 0.68 0.68 0.68 0.68 0.65 0.65 0.65 0.65 0.86 0.86 0.86 0.86 1.11 1.11 1.11 1.11 1.70 1.70 1.696
Debt/Assets 0.46 0.46 0.44 0.44 0.44 0.44 0.42 0.42 0.42 0.42 0.44 0.44 0.44 0.44 0.49 0.49 0.49 0.49 0.56 0.56 0.564
Debt/EBITDA 4.55 4.61 4.55 4.95 4.78 4.59 4.32 4.34 4.97 5.66 6.54 7.58 7.82 8.96 10.27 11.01 -5.97 -6.34 -6.23 -7.43 -7.430
Net Debt/EBITDA 3.26 3.30 3.15 3.43 3.31 3.18 3.11 3.12 3.57 4.08 5.34 6.19 6.38 7.31 8.85 9.49 -5.15 -5.47 -5.42 -6.47 -6.466
Interest Coverage 3.82 4.32 4.82 4.35 4.68 4.91 5.16 5.03 4.07 3.26 2.58 1.87 1.46 0.82 0.74 0.42 -6.03 -5.59 -5.44 -4.52 -4.518
Equity Multiplier 2.39 2.39 2.24 2.24 2.24 2.24 2.16 2.16 2.16 2.16 2.38 2.38 2.38 2.38 2.61 2.61 2.61 2.61 3.45 3.45 3.452
Cash Ratio snapshot only 0.578
Debt Service Coverage snapshot only -2.902
Cash to Debt snapshot only 0.130
FCF to Debt snapshot only -0.005
Defensive Interval snapshot only 263.7 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.44 0.44 0.42 0.42 0.42 0.42 0.41 0.41 0.40 0.40 0.40 0.40 0.41 0.41 0.41 0.42 0.41 0.42 0.43 0.43 0.431
Inventory Turnover 1.85 1.88 1.91 1.89 1.89 1.90 1.83 1.85 1.93 1.98 1.84 1.88 1.93 1.98 1.78 1.84 1.88 1.87 1.71 1.67 1.669
Receivables Turnover 6.03 6.09 6.74 6.82 6.85 6.84 6.29 6.31 6.24 6.23 5.90 5.85 5.99 5.99 6.06 6.11 6.10 6.18 5.93 5.97 5.967
Payables Turnover 6.90 7.02 10.27 10.21 10.16 10.23 7.17 7.23 7.55 7.74 6.76 6.90 7.09 7.26 8.33 8.63 8.79 8.74 8.87 8.63 8.635
DSO 61 60 54 54 53 53 58 58 58 59 62 62 61 61 60 60 60 59 62 61 61.2 days
DIO 197 194 192 193 194 192 199 198 189 185 198 194 189 185 205 198 194 196 213 219 218.6 days
DPO 53 52 36 36 36 36 51 50 48 47 54 53 52 50 44 42 42 42 41 42 42.3 days
Cash Conversion Cycle 205 202 210 210 211 210 207 205 200 196 206 204 199 195 222 215 213 213 233 238 237.5 days
Fixed Asset Turnover snapshot only 2.812
Operating Cycle snapshot only 279.8 days
Cash Velocity snapshot only 6.235
Capital Intensity snapshot only 2.190
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 8.8% 10.7% 12.4% 13.2% 3.8% 2.6% 1.0% 0.2% -1.4% -1.4% -1.0% -2.1% 1.4% 1.4% 4.5% 6.2% 3.5% 5.0% 1.5% 1.2% 1.24%
Net Income 60.1% 2.8% 26.3% -8.0% -19.1% -20.1% 6.8% 9.8% -21.1% -41.7% -62.5% -76.6% -82.0% -1.1% -1.1% -1.7% -22.2% -74.7% -73.4% -16.1% -16.12%
EPS 59.6% 2.8% 25.0% -6.9% -17.4% -18.1% 9.5% 12.4% -18.7% -39.1% -59.9% -75.2% -81.1% -1.1% -1.1% -1.7% -22.4% -74.4% -73.6% -16.0% -16.01%
FCF 4.8% 89.8% 65.3% 4.1% -27.4% -36.0% -17.8% -14.1% -24.2% -41.7% -66.4% -69.5% -62.1% -65.3% -79.5% -1.4% -1.8% -1.4% -4.0% 60.2% 60.24%
EBITDA 1.2% 34.7% 30.3% 2.6% -4.3% 1.1% 3.0% 11.7% -5.8% -20.7% -31.8% -41.0% -34.5% -34.7% -24.9% -18.7% -2.5% -2.7% -2.7% -2.5% -2.52%
Op. Income 2.4% 42.2% 30.3% 37.2% 14.5% 19.6% 21.1% 7.7% -17.6% -37.5% -53.3% -65.5% -65.0% -79.9% -74.5% -88.7% -8.9% -16.7% 1.4% 12.8% 12.84%
OCF Growth snapshot only -30.21%
Asset Growth snapshot only -10.78%
Equity Growth snapshot only -32.47%
Debt Growth snapshot only 2.45%
Shares Change snapshot only 0.64%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 3.3% 1.5% 1.6% 1.9% 1.6% 1.3% 0.9% 1.1% 3.7% 3.8% 4.0% 3.5% 1.3% 0.9% 1.5% 1.4% 1.2% 1.6% 1.6% 1.7% 1.73%
Revenue 5Y 9.6% 9.3% 9.2% 9.0% 8.4% 7.8% 5.6% 4.0% 2.4% 1.1% 0.9% 0.7% 1.0% 0.8% 1.2% 1.4% 3.2% 3.6% 3.6% 3.6% 3.61%
EPS 3Y 42.2% 39.8% 41.1% 24.7% 19.3% 43.6% 55.1% 88.9% 23.8% -18.1% -36.2% -49.8%
EPS 5Y 90.8% 28.1% 16.8% 16.6% 19.1% 27.6% 21.6% 19.2% 14.1% 6.4% 4.3% -11.6% -23.6%
Net Income 3Y 43.3% 39.3% 40.6% 23.8% 18.1% 42.3% 53.2% 86.2% 21.3% -20.3% -38.2% -51.4%
Net Income 5Y 93.9% 29.5% 18.4% 18.3% 20.4% 28.9% 22.8% 19.9% 13.4% 4.7% 2.2% -13.4% -25.2%
EBITDA 3Y 4.4% 1.6% 2.0% 1.0% 4.9% 20.4% 26.8% 28.2% 25.8% 2.6% -2.9% -12.2% -16.1% -19.4% -19.2% -18.8%
EBITDA 5Y 11.5% 10.0% 10.2% 8.1% 8.1% 8.6% 7.1% 4.8% 0.5% -3.4% -5.7% -7.4% -6.6% -2.0% 0.9% 0.2%
Gross Profit 3Y 3.5% 1.9% 1.6% 1.6% 1.6% 0.9% 0.6% 0.9% 2.7% 2.0% 1.3% 0.6% -1.9% -2.8% -2.3% -3.4% -4.4% -3.2% -4.5% -3.3% -3.35%
Gross Profit 5Y 9.0% 8.5% 8.0% 7.8% 7.3% 6.7% 5.2% 4.1% 2.0% 0.5% -0.4% -1.3% -1.2% -1.9% -1.5% -1.6% -0.1% 0.6% -0.1% 0.7% 0.71%
Op. Income 3Y 39.5% 31.6% 21.1% 21.8% 17.5% 35.7% 36.6% 37.3% 47.5% 2.1% -9.7% -20.1% -30.9% -46.8% -47.6% -65.2% -34.1% -18.5% -18.53%
Op. Income 5Y 19.7% 14.2% 11.3% 15.6% 17.7% 24.0% 39.8% 30.6% 20.7% 11.2% 0.1% -7.6% -14.1% -20.7% -21.2% -36.8% -14.7% -4.4% -4.38%
FCF 3Y 53.7% 42.0% 29.4% 28.6% 10.1% 58.9% 30.9% 34.1% 47.5% -10.9% -23.0% -35.1% -40.7% -49.4% -61.6%
FCF 5Y 29.5% 25.1% 30.8% 23.6% 27.4% 26.3% 25.1% 20.8% 14.9% 1.3% -9.7% -11.0% -17.4% -4.1% -31.1%
OCF 3Y 32.1% 24.3% 16.1% 15.3% 4.6% 10.3% 4.5% 3.4% 5.4% -7.8% -11.8% -19.9% -23.0% -24.8% -25.5% -29.1% -35.4% -28.9% -42.5% -33.8% -33.80%
OCF 5Y 23.5% 19.0% 21.8% 17.9% 18.8% 17.8% 18.2% 14.1% 9.1% -0.2% -6.9% -7.1% -9.2% -5.8% -11.0% -14.4% -16.8% -15.9% -24.4% -22.3% -22.29%
Assets 3Y 4.0% 4.0% 6.8% 6.8% 6.8% 6.8% 5.6% 5.6% 5.6% 5.6% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2% 2.2% 2.2% -2.5% -2.5% -2.53%
Assets 5Y 15.3% 15.3% 15.9% 15.9% 15.9% 15.9% 3.9% 3.9% 3.9% 3.9% 4.0% 4.0% 4.0% 4.0% 4.1% 4.1% 4.1% 4.1% -0.1% -0.1% -0.07%
Equity 3Y 16.3% 16.3% 7.0% 7.0% 7.0% 7.0% 8.4% 8.4% 8.4% 8.4% 1.6% 1.6% 1.6% 1.6% -2.8% -2.8% -2.8% -2.8% -16.7% -16.7% -16.69%
Book Value 3Y 15.5% 16.7% 7.4% 7.8% 8.1% 8.0% 9.7% 9.9% 10.0% 10.6% 4.4% 4.8% 4.9% 5.4% 0.7% 0.4% 0.1% -0.1% -14.3% -14.8% -14.79%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.76 0.66 0.64 0.66 0.78 0.75 0.70 0.67 0.82 0.45 0.34 0.29 0.76 0.74 0.69 0.53 0.82 0.85 0.90 0.89 0.887
Earnings Stability 0.33 0.43 0.57 0.44 0.33 0.60 0.82 0.58 0.27 0.24 0.18 0.03 0.00 0.03 0.12 0.16 0.40 0.52 0.62 0.70 0.696
Margin Stability 0.99 0.98 0.98 0.97 0.97 0.98 0.99 0.99 0.99 0.98 0.97 0.96 0.96 0.95 0.94 0.93 0.93 0.93 0.92 0.93 0.927
Rev. Growth Consistency 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 1.00 0.00 0.00 0.00 1.00 0.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0
Earnings Persistence 0.20 0.50 0.89 0.97 0.50 0.92 0.97 0.96 0.92 0.83 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.50 0.500
Earnings Smoothness 0.00 0.77 0.92 0.79 0.78 0.93 0.91 0.76 0.47 0.09 0.00 0.00
ROE Trend 0.10 0.10 0.04 0.03 0.03 0.01 0.01 -0.01 -0.04 -0.07 -0.06 -0.07 -0.07 -0.08 -0.08 -0.08 -0.37 -0.35 -0.51 -0.48 -0.478
Gross Margin Trend -0.00 -0.01 -0.01 0.00 0.01 0.00 0.01 0.00 -0.02 -0.03 -0.04 -0.06 -0.05 -0.05 -0.05 -0.06 -0.05 -0.03 -0.04 -0.02 -0.016
FCF Margin Trend 0.12 0.12 0.08 0.04 0.02 -0.03 -0.00 -0.03 -0.06 -0.09 -0.11 -0.10 -0.08 -0.07 -0.08 -0.10 -0.10 -0.06 -0.06 -0.02 -0.018
Sustainable Growth Rate 14.0% 14.8% 10.6% 9.8% 10.4% 10.8% 10.3% 9.9% 7.5% 5.8% 4.0% 2.4% 1.4%
Internal Growth Rate 6.3% 6.7% 4.8% 4.4% 4.7% 4.9% 4.9% 4.7% 3.5% 2.7% 1.8% 1.1% 0.6%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.51 1.49 1.85 1.84 1.58 1.44 1.46 1.43 1.59 1.65 2.07 3.22 5.99 -21.00 -18.63 -3.54 -0.14 -0.18 -0.10 -0.14 -0.144
FCF/OCF 0.91 0.91 0.85 0.81 0.78 0.76 0.82 0.81 0.75 0.66 0.52 0.47 0.42 0.28 0.12 -0.25 -0.67 -0.16 -0.90 -0.14 -0.142
FCF/Net Income snapshot only 0.020
CapEx/Revenue 1.9% 1.9% 3.1% 3.6% 3.7% 3.8% 3.0% 3.0% 3.4% 3.7% 4.3% 4.5% 5.3% 6.3% 7.1% 7.9% 7.3% 6.3% 5.8% 5.0% 4.96%
CapEx/Depreciation snapshot only 0.536
Accruals Ratio -0.03 -0.03 -0.04 -0.04 -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.04 -0.03 -0.03 -0.15 -0.15 -0.15 -0.15 -0.149
Sloan Accruals snapshot only 0.103
Cash Flow Adequacy snapshot only 0.876
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Total Payout Ratio 0.0% 0.0% 0.3% 80.2% 75.5% 72.6% 69.4% 87.4% 1.1% 2.7% 4.1% 3.1% 7.4%
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 2.3% 2.8% 3.6% 2.7% 3.2% 4.5% 9.0% 8.1% 4.5% 7.8% 3.6% 3.0% 3.1% 0.3% 0.2% 0.0% 0.0% 0.03%
Net Buyback Yield -0.1% -0.1% -0.1% 2.2% 2.7% 3.5% 2.7% 3.2% 4.5% 9.0% 8.0% 4.3% 7.5% 3.2% 2.6% 3.1% 0.2% 0.2% -0.1% -0.1% -0.07%
Total Shareholder Return -0.1% -0.1% -0.1% 2.2% 2.7% 3.5% 2.7% 3.2% 4.5% 9.0% 8.0% 4.3% 7.5% 3.2% 2.6% 3.1% 0.2% 0.2% -0.1% -0.1% -0.07%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.07 1.07 0.79 0.84 0.86 0.86 0.84 0.84 0.84 0.87 0.84 0.87 0.87 0.55 0.38 0.67 0.90 0.91 0.92 0.93 0.925
Interest Burden (EBT/EBIT) 0.79 0.84 0.88 0.87 0.86 0.84 0.84 0.81 0.77 0.71 0.61 0.47 0.31 -0.22 -0.35 -1.31 1.16 1.18 1.18 1.26 1.258
EBIT Margin 0.16 0.16 0.16 0.14 0.14 0.15 0.16 0.16 0.13 0.11 0.09 0.06 0.05 0.03 0.03 0.02 -0.30 -0.28 -0.29 -0.26 -0.259
Asset Turnover 0.44 0.44 0.42 0.42 0.42 0.42 0.41 0.41 0.40 0.40 0.40 0.40 0.41 0.41 0.41 0.42 0.41 0.42 0.43 0.43 0.431
Equity Multiplier 2.36 2.36 2.31 2.31 2.31 2.31 2.20 2.20 2.20 2.20 2.26 2.26 2.26 2.26 2.50 2.50 2.50 2.50 2.95 2.95 2.951
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $2.41 $2.53 $1.97 $1.86 $1.99 $2.07 $2.16 $2.09 $1.62 $1.26 $0.86 $0.52 $0.31 $-0.09 $-0.09 $-0.38 $-6.55 $-6.45 $-6.73 $-6.44 $-6.44
Book Value/Share $17.75 $17.73 $19.64 $19.99 $20.15 $20.20 $21.57 $21.92 $22.24 $22.61 $20.27 $20.43 $20.51 $20.77 $20.07 $20.21 $20.21 $20.13 $13.60 $13.56 $13.55
Tangible Book/Share $-4.77 $-4.76 $-5.53 $-5.63 $-5.67 $-5.69 $-4.32 $-4.39 $-4.45 $-4.52 $-6.84 $-6.89 $-6.92 $-7.00 $-9.86 $-9.93 $-9.93 $-9.89 $-9.20 $-9.18 $-9.18
Revenue/Share $17.68 $17.85 $17.98 $18.50 $18.74 $18.77 $18.62 $18.97 $19.04 $19.33 $19.68 $19.68 $20.24 $20.47 $20.91 $21.24 $21.21 $21.41 $21.31 $21.37 $21.37
FCF/Share $3.30 $3.45 $3.08 $2.76 $2.45 $2.26 $2.60 $2.42 $1.91 $1.38 $0.93 $0.78 $0.76 $0.50 $0.19 $-0.33 $-0.62 $-0.19 $-0.59 $-0.13 $-0.13
OCF/Share $3.64 $3.78 $3.64 $3.41 $3.14 $2.98 $3.16 $2.99 $2.56 $2.09 $1.79 $1.67 $1.83 $1.80 $1.68 $1.34 $0.93 $1.16 $0.66 $0.93 $0.93
Cash/Share $5.51 $5.50 $5.99 $6.09 $6.14 $6.16 $5.46 $5.55 $5.63 $5.72 $3.95 $3.98 $3.99 $4.04 $3.55 $3.58 $3.58 $3.56 $3.44 $3.43 $3.45
EBITDA/Share $4.26 $4.20 $4.27 $3.99 $4.17 $4.35 $4.51 $4.57 $4.04 $3.61 $3.28 $2.85 $2.78 $2.46 $2.51 $2.36 $-4.34 $-4.08 $-4.25 $-3.56 $-3.56
Debt/Share $19.40 $19.37 $19.42 $19.77 $19.92 $19.98 $19.48 $19.80 $20.09 $20.42 $21.47 $21.63 $21.72 $22.00 $25.77 $25.95 $25.95 $25.86 $26.49 $26.42 $26.42
Net Debt/Share $13.89 $13.87 $13.44 $13.68 $13.78 $13.82 $14.03 $14.25 $14.46 $14.70 $17.52 $17.66 $17.73 $17.95 $22.22 $22.38 $22.38 $22.29 $23.05 $22.99 $22.99
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 0.635
Altman Z-Prime snapshot only 1.167
Piotroski F-Score 8 7 7 8 8 7 8 7 6 6 5 4 5 4 5 5 5 5 5 5 5
Beneish M-Score -2.60 -2.78 -2.58 -2.60 -2.54 -2.48 -2.45 -2.44 -2.36 -2.41 -2.55 -2.57 -2.65 -2.65 -2.55 -2.52 -3.02 -3.10 -3.21 -3.34 -3.342
Ohlson O-Score snapshot only -5.219
Net-Net WC snapshot only $-18.18
EVA snapshot only $-183410390.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only B+
Credit Score 59.49 59.53 59.65 59.89 56.09 56.36 69.26 67.57 56.33 55.07 50.55 47.20 38.87 35.03 22.82 21.78 23.50 23.42 31.04 30.59 30.594
Credit Grade snapshot only 14
Credit Trend snapshot only 8.818
Implied Spread (bps) snapshot only 650.000
Industry Credit Rank snapshot only 23
Sector Credit Rank snapshot only 19

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms